News Daily News ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly L.A. McKeown December 22, 2022
News Daily News Delaying Surgery After COVID-19 Cuts Risk of CV Complications Yael L. Maxwell December 19, 2022
News Daily News ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA Todd Neale December 16, 2022
News Daily News Impella RP Mortality Rate No Longer a Concern, FDA Says Caitlin E. Cox December 05, 2022
News Conference News AHA 2022 Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI Shelley Wood November 10, 2022
News Daily News Guideline Guidance: Practical Tips for Finding, Triaging Chest Pain in the ED Yael L. Maxwell October 12, 2022
News Daily News CV Risk Factors or Preexisting CVD: What’s Worse for COVID-19? Caitlin E. Cox October 11, 2022
News Daily News Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues Michael O'Riordan October 03, 2022
News Daily News Monkeypox and the Heart: Acute Myocarditis Rare, With Good Outlook L.A. McKeown September 02, 2022
News Daily News Stable Chest Pain Guideline Data Standards Developed to Add Uniformity Yael L. Maxwell September 02, 2022
News Conference News ESC 2022 Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke Todd Neale August 28, 2022
News Daily News ‘Stunning’ Lack of Data on CV Issues in Pregnant Women With COVID-19 L.A. McKeown August 10, 2022
News Daily News Early LV Recovery After TAVI Points to Better 5-Year Survival Yael L. Maxwell August 01, 2022
News Daily News Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients Caitlin E. Cox July 20, 2022
News Daily News hs-Troponins and the Chest Pain Guidelines: Experts Call for Clarification Yael L. Maxwell July 08, 2022
News Daily News EMERGE: Early Angiography Doesn’t Boost OHCA Survival After NSTEMI Caitlin E. Cox June 14, 2022
News Daily News Neurologic, Psychiatric Risks Linger Among Adult Cardiac Arrest Survivors Todd Neale June 03, 2022
News Conference News ESC Heart Failure 2022 Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE Todd Neale May 31, 2022
News Daily News Lingering Symptoms After COVID-19 Tied to Heart, Lung, and Kidney Injury Todd Neale May 30, 2022